DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

Information source: Nationwide Children's Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Neonates and Infants Who Have Received Chloroprocaine for Epidural Anesthesia.

Intervention: Chloroprocaine (Drug)

Phase: N/A

Status: Completed

Sponsored by: Joseph D. Tobias

Official(s) and/or principal investigator(s):
Joseph D Tobias, MD, Principal Investigator, Affiliation: Nationwide Children's Hospital


This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Clinical Details

Study design: Observational Model: Cohort, Time Perspective: Retrospective

Primary outcome: Pain score

Secondary outcome: Pain medicine consumption


Minimum age: N/A. Maximum age: 2 Years. Gender(s): Both.


Inclusion Criteria:

- Neonates and infants who have received chloroprocaine for epidural anesthesia.

Exclusion Criteria:

- None

Locations and Contacts

Nationwide Children's Hospital, Columbus, Ohio 43205, United States
Additional Information

Starting date: June 2014
Last updated: August 5, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017